Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

The document discusses various skin disorders and new therapeutic approaches.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Magnesium oxide-infused membranes help heal wounds faster by reducing inflammation and promoting skin and hair follicle growth.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

VR1 signaling can inhibit hair growth by affecting cell processes and increasing hair growth inhibitors.

Understanding the genetics of alopecia areata could lead to better treatments.

The plant extract and minoxidil both reduce hair loss by lowering specific gene expressions.

The plant extract may help prevent hair loss by reducing inflammation and promoting hair growth.

Certain proteins and cytokines are key in causing psoriatic skin issues.

Myrtus communis leaf extract may help with hair loss and wound healing.

Myrtus communis leaf extract may help with hair loss and wound healing.

Tectona grandis leaves may help treat hair loss and inflammation.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Isotretinoin effectively treats severe acne but can affect blood and inflammation markers, posing risks for some people.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

IL-15 promotes hair growth and protects hair follicles.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

IL-17 and certain immune cells are linked to more severe alopecia areata.